Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Hypersensitivity Reaction

  Free Subscription

Articles published in J Dermatol

Retrieve available abstracts of 99 articles:
HTML format

Single Articles

    November 2021
  1. MATSUMOTO Y, Imamura S, Fukumoto A, Lee K, et al
    Case of oral mite anaphylaxis: Contamination of wheat flour by mites determined by enzyme-linked immunosorbent assay.
    J Dermatol. 2021 Nov 18. doi: 10.1111/1346-8138.16227.

  2. NAKAMURA R, Tanaka A, Kinoshita H, Ishii K, et al
    Minocycline-induced anaphylaxis mediated by antigen-specific immunoglobulin E.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16228.

  3. HASHIZUME H, Ishikawa Y, Ajima S
    Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16230.
    PubMed     Abstract available

  4. TOUBI E, Vadasz Z
    Predictive features associated with chronic spontaneous urticaria recurrence.
    J Dermatol. 2021;48:1786-1788.
    PubMed     Abstract available

  5. WU RW, Lin TK
    Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis.
    J Dermatol. 2021;48:e562-e563.

  6. MAURELLI M, Bellinato F, Girolomoni G
    Adrenergic urticaria successfully treated with omalizumab.
    J Dermatol. 2021;48:e541-e542.

  7. CHEN TL, Yip HT, Wang JH, Chang CH, et al
    Risk of chronic spontaneous urticaria in reproductive-aged women with abnormal uterine bleeding: A population-based cohort study.
    J Dermatol. 2021;48:1754-1762.
    PubMed     Abstract available

  8. OKU A, Nakai K, Ikenaga T, Sato K, et al
    Case of afatinib-induced severe purpuric drug eruption with gastrointestinal bleeding.
    J Dermatol. 2021;48:e534-e535.

    October 2021
  9. MIURA S, Moriyama T, Yoshimura J, Umehara K, et al
    Anaphylaxis to lipid transfer protein from butterbur scape.
    J Dermatol. 2021 Oct 29. doi: 10.1111/1346-8138.16213.

  10. GOTO T, Kogure A, Kuwano Y
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
    J Dermatol. 2021 Oct 8. doi: 10.1111/1346-8138.16190.

  11. KAGE P, Simon JC, Treudler R
    Case of atopic eczema treated with dupilumab throughout conception, pregnancy, and lactation.
    J Dermatol. 2021;48:E484-E485.

  12. KURIYAMA Y, Shimizu A, Oka H, Sato M, et al
    Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries.
    J Dermatol. 2021;48:1588-1592.
    PubMed     Abstract available

  13. LIU KL, Tsai TL, Tsai WC, Tsai SF, et al
    Prenatal heavy metal exposure, total immunoglobulin E, trajectory, and atopic diseases: A 15-year follow-up study of a Taiwanese birth cohort.
    J Dermatol. 2021;48:1542-1549.
    PubMed     Abstract available

    September 2021
  14. HUANG HL, Xu HM, Liu YD, Shou DW, et al
    Fecal microbiota transplantation as a novel approach for the treatment of atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16169.

  15. KIDO-NAKAHARA M, Yokote G, Yoshida M, Furue M, et al
    Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16176.

  16. ZHANG L, Du D, Wang L, Guo L, et al
    Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis.
    J Dermatol. 2021 Sep 6. doi: 10.1111/1346-8138.16126.
    PubMed     Abstract available

  17. TOTSUKA M, Watanabe T, Takamura N, Watanabe Y, et al
    A pediatric case of Stevens-Johnson syndrome with acute liver failure, resulting in liver transplantation.
    J Dermatol. 2021;48:1423-1427.
    PubMed     Abstract available

  18. KOMATSUDA E, Enzan N, Kono M
    Prochlorperazine-induced photoallergic reaction confirmed by photopatch test.
    J Dermatol. 2021;48:e464-e465.

  19. FUKUMURA E, Nakai K, Togo S, Tokimasa S, et al
    Case of Muckle-Wells syndrome with obesity.
    J Dermatol. 2021;48:e438-e439.

    August 2021
  20. CHANG PH, Huang SF, Chang PS, Yu Y, et al
    Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications.
    J Dermatol. 2021 Aug 30. doi: 10.1111/1346-8138.16116.
    PubMed     Abstract available

  21. RAGAMIN A, de Wijs LEM, Hijnen DJ, Arends NJT, et al
    Care for children with atopic dermatitis in the Netherlands during the COVID-19 pandemic: Lessons from the first wave and implications for the future.
    J Dermatol. 2021 Aug 29. doi: 10.1111/1346-8138.16130.
    PubMed     Abstract available

  22. FUJITA K, Yagi M, Moriwaki S, Yoshida M, et al
    A phase 2b, randomized, double-blind, multicenter, vehicle-controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild-to-moderate atopic dermatitis.
    J Dermatol. 2021 Aug 26. doi: 10.1111/1346-8138.16120.
    PubMed     Abstract available

  23. KAWANO N, Inoue H, Shiratori T
    Onset of Stevens-Johnson syndrome and toxic epidermal necrolysis overlap due to tirabrutinib.
    J Dermatol. 2021 Aug 4. doi: 10.1111/1346-8138.16093.

  24. YASUNO S, Ansai O, Hayashi R, Nakamura S, et al
    Evidence for a dominant-negative effect of a missense mutation in the SERPING1 gene responsible for hereditary angioedema type I.
    J Dermatol. 2021;48:1243-1249.
    PubMed     Abstract available

    July 2021
  25. OTA M, Sasaki T, Ebihara T, Yokosawa E, et al
    Filaggrin-gene mutation has minimal effect on the disease severity in the lesions of atopic dermatitis.
    J Dermatol. 2021 Jul 29. doi: 10.1111/1346-8138.16087.
    PubMed     Abstract available

  26. TANAKA A, Morioke S, Ohya Y, Shimojo N, et al
    Comparison of the time course of atopic dermatitis from birth to 19 years old among generations of patients in Japan.
    J Dermatol. 2021 Jul 27. doi: 10.1111/1346-8138.16085.
    PubMed     Abstract available

  27. TAMAGAWA-MINEOKA R, Maruyama A, Ioka N, Masuda K, et al
    Allergic contact dermatitis due to didecyldimethylammonium chloride included in a swimsuit.
    J Dermatol. 2021 Jul 27. doi: 10.1111/1346-8138.16086.

  28. SONG D, Ran X, Chen Y, Li Z, et al
    Recurrent c.459 C>A mutation of the PERP gene results in severe Olmsted syndrome with congenital hypotrichosis, atopic dermatitis, and growth retardation.
    J Dermatol. 2021 Jul 15. doi: 10.1111/1346-8138.16060.

  29. KAMEI K, Hirose T, Yoshii N, Tanaka A, et al
    Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: A retrospective analysis of a cross-sectional questionnaire survey.
    J Dermatol. 2021 Jul 6. doi: 10.1111/1346-8138.16054.
    PubMed     Abstract available

  30. HASHIMOTO H, Ito T, Ohno F, Morisawa H, et al
    Severe drug eruption induced by cyclin-dependent kinase 4 and 6 inhibitor.
    J Dermatol. 2021;48:e339-e340.

    June 2021
  31. OSADA A, Arimitsu T, Nakazaki H, Kin T, et al
    Severe drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms in a 1-month-old infant with trisomy 21.
    J Dermatol. 2021 Jun 28. doi: 10.1111/1346-8138.16042.

  32. MATSUTANI M, Imai Y, Inoue Y, Nakatani-Kusakabe M, et al
    Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice.
    J Dermatol. 2021 Jun 22. doi: 10.1111/1346-8138.16039.
    PubMed     Abstract available

  33. UCHIDA H, Kamata M, Nagata M, Fukaya S, et al
    Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report.
    J Dermatol. 2021 Jun 20. doi: 10.1111/1346-8138.16024.

  34. HANADA M, Nakagawa M, Hamabata A, Amano H, et al
    Lipid transfer protein syndrome due to wild grape juice and various vegetables: A life-threatening food allergen.
    J Dermatol. 2021 Jun 11. doi: 10.1111/1346-8138.16010.
    PubMed     Abstract available

  35. WANG Q, Lan YP, Qi B, Yin L, et al
    Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2021 Jun 1. doi: 10.1111/1346-8138.15968.
    PubMed     Abstract available

    May 2021
  36. OLLECH A, Mashiah J, Lev A, Simon AJ, et al
    Treatment options for DOCK8 deficiency-related severe dermatitis.
    J Dermatol. 2021 May 27. doi: 10.1111/1346-8138.15955.
    PubMed     Abstract available

  37. HASHIZUME H, Fujiyama T, Kageyama R, Kaneko Y, et al
    Increased CD30(+) cells in skin lesions of drug-induced hypersensitivity syndrome: Are type-2 innate lymphoid cells present?
    J Dermatol. 2021 May 25. doi: 10.1111/1346-8138.15967.

  38. BOSMA AL, Ouwerkerk W, Gunal M, Hyseni AM, et al
    Work ability and quality of working life in atopic dermatitis patients treated with dupilumab.
    J Dermatol. 2021 May 19. doi: 10.1111/1346-8138.15939.
    PubMed     Abstract available

  39. ARAKAWA N, Inoue T, Tanji T, Amano H, et al
    Development of arthralgia during treatment with dupilumab in a patient with atopic dermatitis.
    J Dermatol. 2021 May 14. doi: 10.1111/1346-8138.15965.

  40. SHIN HT, Lee SH, Yoon HS, Heo JH, et al
    Long-term efficacy and safety of intravenous injection of clonal mesenchymal stem cells derived from bone marrow in five adults with moderate to severe atopic dermatitis.
    J Dermatol. 2021 May 14. doi: 10.1111/1346-8138.15928.
    PubMed     Abstract available

  41. KAWAI R, Suzuki S, Tanaka A, Yamazaki M, et al
    Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine.
    J Dermatol. 2021 May 8. doi: 10.1111/1346-8138.15918.

  42. LUGER T, Adaskevich U, Anfilova M, Dou X, et al
    Practical algorithm to inform clinical decision-making in the topical treatment of atopic dermatitis.
    J Dermatol. 2021 May 7. doi: 10.1111/1346-8138.15921.
    PubMed     Abstract available

  43. HAYASHI E, Imanishi H, Tateishi C, Sowa-Osako J, et al
    Acute generalized exanthematous pustulosis associated with human parvovirus B19 infection in an adolescent.
    J Dermatol. 2021;48:e236-e237.

    April 2021
  44. UJIIE I, Iwata H, Yoshimoto N, Izumi K, et al
    Clinical characteristics and outcomes of bullous pemphigoid patients with versus without oral prednisolone treatment.
    J Dermatol. 2021;48:502-510.
    PubMed     Abstract available

  45. MURASE C, Takeichi T, Sugiura K, Akiyama M, et al
    Acute generalized exanthematous pustulosis triggered by acetaminophen in an IL36RN variant heterozygote.
    J Dermatol. 2021;48:e186-e187.

  46. ITAMI A, Miyagaki T, Miyano K, Takeuchi S, et al
    Intravascular large B-cell lymphoma mimicking erythema nodosum: A case report and review of published works.
    J Dermatol. 2021;48:e184-e185.

    March 2021
  47. KONDO M, Taniguchi T, Umaoka A, Iida S, et al
    Immunoglobulin G levels against Staphylococcus aureus maintained before and after treatment of severe atopic dermatitis.
    J Dermatol. 2021 Mar 28. doi: 10.1111/1346-8138.15871.

  48. FURUKAWA H, Omura R, Sugiura K, Kanazawa N, et al
    Granular C3 dermatosis-like immunological manifestation found in a case of acute generalized exanthematous pustulosis: Implication for the mechanism in C3 deposition to the epidermal basement membrane zone.
    J Dermatol. 2021 Mar 21. doi: 10.1111/1346-8138.15853.

  49. TAKEUCHI S, Inoue K, Kuretake K, Kiyomatsu-Oda M, et al
    Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
    J Dermatol. 2021 Mar 20. doi: 10.1111/1346-8138.15843.
    PubMed     Abstract available

  50. VERGARA-DE-LA-CAMPA L, Torrado I, Recuero-Pradillo M, Torrelo A, et al
    Mastocytosis in the skin accompanied by pseudo-Kaposi's sarcoma.
    J Dermatol. 2021 Mar 8. doi: 10.1111/1346-8138.15734.
    PubMed     Abstract available

  51. WOO YR, Han Y, Lee JH, Lee YB, et al
    Real-world prevalence and burden of genital eczema in atopic dermatitis: A multicenter questionnaire-based study.
    J Dermatol. 2021 Mar 5. doi: 10.1111/1346-8138.15817.
    PubMed     Abstract available

    February 2021
  52. NOMURA T, Nakajima S, Kashiwa A, Matsuyama K, et al
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic syndrome followed by transient palmoplantar keratoderma-like eruption.
    J Dermatol. 2021 Feb 25. doi: 10.1111/1346-8138.15820.

  53. TANAKA A, Morioke S, Ohya Y, Shimojo N, et al
    Time course of disease severity from birth to 19 years old in patients with moderate to severe atopic dermatitis in adulthood.
    J Dermatol. 2021 Feb 23. doi: 10.1111/1346-8138.15790.

  54. JO UH, Lee JY, Lee H, Kim DY, et al
    Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population.
    J Dermatol. 2021 Feb 19. doi: 10.1111/1346-8138.15676.
    PubMed     Abstract available

  55. SAEKI H
    Preface to Journal of Dermatology special issue: Atopic dermatitis.
    J Dermatol. 2021;48:129.

  56. FUJII M, Kishibe M, Ishida-Yamamoto A
    Case of hypocomplementemic urticarial vasculitis with Sjogren's syndrome successfully treated with oral corticosteroid and colchicine.
    J Dermatol. 2021;48:e112-e113.

  57. NAGAOKA S, Hayashi S, Mori S, Kaneko Y, et al
    A case of macular rash misleading to drug eruption in secondary syphilis.
    J Dermatol. 2021;48:e104-e105.

  58. KADOWAKI S, Kimura T, Shiraki M, Mizutani Y, et al
    Case of Muckle-Wells syndrome with erythema dominantly infiltrated by lymphocytes.
    J Dermatol. 2021;48:e100-e101.

    January 2021
  59. TANAKA A, Isei M, Kikuzawa C, Hinogami H, et al
    Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA.
    J Dermatol. 2021 Jan 13. doi: 10.1111/1346-8138.15753.

  60. SUGIOKA K, Goto H, Sugita K, Habe K, et al
    Palisaded neutrophilic granulomatous dermatitis, interstitial granulomatous dermatitis and IgA vasculitis associated with incomplete Sjogren's syndrome.
    J Dermatol. 2021 Jan 6. doi: 10.1111/1346-8138.15738.
    PubMed     Abstract available

  61. BOSMA AL, Ouwerkerk W, Middelkamp-Hup MA
    Children with atopic eczema experiencing increased disease severity in the pollen season more often have hay fever at a young age and a dark skin type.
    J Dermatol. 2021 Jan 6. doi: 10.1111/1346-8138.15750.
    PubMed     Abstract available

  62. SCHIELEIN MC, Tizek L, Baeumer D, Hillmann E, et al
    People-centered care for psoriasis and urticaria: Are we overlooking Internet addiction while only considering patients and physician settings?
    J Dermatol. 2021 Jan 6. doi: 10.1111/1346-8138.15740.
    PubMed     Abstract available

  63. MATSUBARA D, Takahagi S, Saito R, Kamegashira A, et al
    Analysis of the long-term economic burden of omalizumab on patients with chronic spontaneous urticaria.
    J Dermatol. 2021;48:56-63.
    PubMed     Abstract available

  64. FUKAYAMA M, Domoto Y, Sato S, Asano Y, et al
    Case of aquagenic urticaria: Case report and the results of histopathological examination.
    J Dermatol. 2021;48:88-91.
    PubMed     Abstract available

  65. MAENO M, Tamagawa-Mineoka R, Arakawa Y, Masuda K, et al
    Metal patch testing in patients with oral symptoms.
    J Dermatol. 2021;48:85-87.
    PubMed     Abstract available

    December 2020
  66. MIYANO K, Tsunemi Y
    Current treatments for atopic dermatitis in Japan.
    J Dermatol. 2020 Dec 30. doi: 10.1111/1346-8138.15730.
    PubMed     Abstract available

  67. TEYE K, Koga H, Nagai A, Ohata C, et al
    Filaggrin gene (FLG) promoter polymorphisms are associated with atopic dermatitis in the Japanese population.
    J Dermatol. 2020 Dec 27. doi: 10.1111/1346-8138.15736.

  68. CHIEOSILAPATHAM P, Prinyaroj N, Jamjanya S, Kiratikanon S, et al
    Degos-like lesions as a cutaneous manifestation of cytomegalovirus infection: A rare and serious complication in a patient with drug-induced hypersensitivity syndrome.
    J Dermatol. 2020 Dec 11. doi: 10.1111/1346-8138.15717.
    PubMed     Abstract available

  69. MOTOHASHI I, Takano T, Ie K, Hashimoto Y, et al
    Development of maculopapular exanthem in a COVID-19 patient.
    J Dermatol. 2020;47:e426-e427.

    November 2020
  70. CHIANG PH, Ng CY, Kuo TT, Hui RC, et al
    Case of vitiligo universalis as a sequela of drug-induced hypersensitivity syndrome.
    J Dermatol. 2020 Nov 12. doi: 10.1111/1346-8138.15562.
    PubMed     Abstract available

  71. PUNYARATABANDHU P, Chirachanakul P
    Cutaneous eruption in COVID-19-infected patients in Thailand: An observational descriptive study.
    J Dermatol. 2020 Nov 12. doi: 10.1111/1346-8138.15625.
    PubMed     Abstract available

  72. ICHIYAMA S, Ito M, Hoashi T, Kanda N, et al
    Severe atopic dermatitis effectively treated with dupilumab changed from interleukin-5 inhibitors for concomitant severe bronchial asthma.
    J Dermatol. 2020 Nov 8. doi: 10.1111/1346-8138.15691.

    October 2020
  73. WENG YC, Juan CK, Ho HJ, Chang YL, et al
    Atopic dermatitis does not increase the risk of inflammatory bowel disease: A nationwide cohort study.
    J Dermatol. 2020 Oct 30. doi: 10.1111/1346-8138.15661.
    PubMed     Abstract available

  74. NAKAHARA T, Kido-Nakahara M, Tsuji G, Furue M, et al
    Basics and recent advances in the pathophysiology of atopic dermatitis.
    J Dermatol. 2020 Oct 29. doi: 10.1111/1346-8138.15664.
    PubMed     Abstract available

  75. AJIMA S, Sano Y, Hashizume H
    Quinolone immediate hypersensitivity due to topical ophthalmic preparations: a case report and review of literature.
    J Dermatol. 2020 Oct 28. doi: 10.1111/1346-8138.15669.
    PubMed     Abstract available

  76. SHIIYA C, Ouchi T, Funakoshi T, Amagai M, et al
    Autoimmune and inflammatory diseases occur in cases of drug-induced hypersensitivity syndrome but not in suspected cases.
    J Dermatol. 2020 Oct 18. doi: 10.1111/1346-8138.15639.

  77. ISHIURA N, Yanaba K, Nashiro K, Kudo M, et al
    Inhibitory role of interleukin-10 in the cutaneous reverse Arthus reaction.
    J Dermatol. 2020 Oct 15. doi: 10.1111/1346-8138.15641.
    PubMed     Abstract available

  78. FURUHASHI T, Oda T, Torii K, Nishida E, et al
    Dupilumab probably reduces transepidermal water loss but does not increase stratum corneum hydration in atopic dermatitis.
    J Dermatol. 2020 Oct 9. doi: 10.1111/1346-8138.15638.

  79. MUTO J, Yoshida S, Doi C, Habu M, et al
    Dupilumab treatment of atopic dermatitis leading to successful treatment of alopecia universalis: A Japanese case report.
    J Dermatol. 2020 Oct 7. doi: 10.1111/1346-8138.15631.

    September 2020
  80. BORILOVA LINHARTOVA P, Gachova D, Lipovy B
    Responsiveness to i.v. immunoglobulin therapy in patients with toxic epidermal necrolysis: A novel pharmaco-immunogenetic concept.
    J Dermatol. 2020 Sep 15. doi: 10.1111/1346-8138.15583.
    PubMed     Abstract available

    August 2020
  81. TORRES-NAVARRO I, Briz-Redon A, Botella-Casas G, Sahuquillo-Torralba A, et al
    Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2020 Aug 27. doi: 10.1111/1346-8138.15490.
    PubMed     Abstract available

  82. KAWADA M, Nobeyama Y, Goto Y, Nakama K, et al
    Absence of toxic epidermal necrolysis recurrence with pembrolizumab re-challenge in a patient with a positive lymphocyte transformation test.
    J Dermatol. 2020 Aug 20. doi: 10.1111/1346-8138.15572.

    July 2020
  83. SHEN MH, Liu MT, Chung WH, Lu CW, et al
    Toxic epidermal necrolysis induced by human herpesvirus 7 treated with a tumor necrosis factor-alpha inhibitor.
    J Dermatol. 2020 Jul 19. doi: 10.1111/1346-8138.15493.
    PubMed     Abstract available

  84. KAWASAKI Y, Kamata M, Shimizu T, Nagata M, et al
    Thymus and activation-regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis.
    J Dermatol. 2020 Jul 16. doi: 10.1111/1346-8138.15511.
    PubMed     Abstract available

  85. ENDO Y, Oka A, Uehara A, Toki S, et al
    Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug.
    J Dermatol. 2020 Jul 14. doi: 10.1111/1346-8138.15510.

  86. WATANABE T, Yamaguchi Y, Watanabe Y, Takamura N, et al
    Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
    J Dermatol. 2020 Jul 1. doi: 10.1111/1346-8138.15467.
    PubMed     Abstract available

    May 2020
  87. SEKIGUCHI A, Ishikawa O, Motegi SI
    Case of zinc deficiency-induced dermatomyositis-like dermatitis: Association between absence of CD1a-positive Langerhans cells and development of dermatitis.
    J Dermatol. 2020 May 15. doi: 10.1111/1346-8138.15394.

    April 2020
  88. TOMII K, Deguchi T, Katsumi T, Suzuki T, et al
    Case of toxic epidermal necrolysis successfully treated with repeated i.v. immunoglobulin.
    J Dermatol. 2020 Apr 24. doi: 10.1111/1346-8138.15356.

  89. UETSU N, Nomura Y, Matsuyama Y, Okamoto H, et al
    Characteristics and clinical significance of augmentation spectra in solar urticaria.
    J Dermatol. 2020;47:369-377.
    PubMed     Abstract available

  90. SUO H, Su H, Lu C, Yang L, et al
    Development of generalized bullous lesions after hemodialysis with polysulfone membrane dialyzer.
    J Dermatol. 2020;47:e119-e120.

    February 2020
  91. KONDO M, Suzuki K, Nakayama Y, Matsushima Y, et al
    Case of toxic epidermal necrolysis in immunocompromised patient possibly due to Streptococcus pneumoniae serotype uncovered by vaccine.
    J Dermatol. 2020 Feb 13. doi: 10.1111/1346-8138.15268.

  92. MATSUDA-HIROSE H, Sho Y, Yamate T, Nakamura Y, et al
    Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.
    J Dermatol. 2020;47:e53-e54.

  93. IHIBASHI-KUNIMI Y, Imafuku S
    Cholinergic urticaria with hypohidrosis successfully treated with omalizumab.
    J Dermatol. 2020;47:e47-e48.

    January 2020
  94. KIKUCHI S, Nobeyama Y, Saeki H, Asahina A, et al
    Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication.
    J Dermatol. 2020 Jan 7. doi: 10.1111/1346-8138.15208.
    PubMed     Abstract available

  95. NAKAMURA K, Iwata Y, Asai J, Kawakami T, et al
    Guidelines for the treatment of skin and mucosal lesions in Behcet's disease: A secondary publication.
    J Dermatol. 2020 Jan 6. doi: 10.1111/1346-8138.15207.
    PubMed     Abstract available

  96. SAWADA H, Kanehisa F, Katoh N, Asai J, et al
    Potassium iodide in successful treatment of erythema nodosum-like lesions induced by combination therapy with dabrafenib and trametinib.
    J Dermatol. 2020;47:e7-e8.

    December 2019
  97. TAKAHASHI A, Namikawa K, Nakano E, Yamazaki N, et al
    Real-world efficacy and safety data for dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced melanoma.
    J Dermatol. 2019 Dec 26. doi: 10.1111/1346-8138.15204.
    PubMed     Abstract available

    November 2019
  98. HASHIZUME H, Abe R, Azukizawa H, Fujiyama T, et al
    Confusion in determination of two types of cutaneous adverse reactions to drugs, maculopapular eruption and erythema multiforme, among the experts: A proposal of standardized terminology.
    J Dermatol. 2019 Nov 28. doi: 10.1111/1346-8138.15164.
    PubMed     Abstract available

    September 2019
  99. CHIANG B, Kamiya K, Sashikawa M, Maekawa T, et al
    Rare case of acquired perforating dermatosis induced by cetuximab.
    J Dermatol. 2019 Sep 20. doi: 10.1111/1346-8138.15098.

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.